Biofire Defense

FDA Regulatory Profile

Biofire Defense appears in FDA public data with 3 recalls, 10 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (Z-2609-2025, Class II) was initiated on July 10, 2025. Its most recent 510(k) clearance was granted on July 17, 2026.

Summary

Total Recalls
3
510(k) Clearances
10
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-2609-2025Class IIFilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitrJuly 10, 2025
Z-1448-2020Class IIIFilmArray NGDS Warrior Panel, Ref: NGDS-ASY-0007, UDI: (01)00851458005136, IVD, Rx OnlyAugust 20, 2019
Z-2644-2014Class IIIJBAIDS Instrument System Software version 3.5.0.72. The JBAIDS instrument is a portable thermocycAugust 13, 2014

Recent 510(k) Clearances

K-NumberDeviceDate
K261475BIOFIRE® FILMARRAY® Tropical Fever Panel Control KitJuly 17, 2026
K243822BioFire Warrior Panel; BioFire Warrior Panel Control KitMarch 12, 2025
K213362BioFire Global Fever Special Pathogens Panel; BIOFIRE SHIELD Control Kit for the BioFire Global FeveMarch 22, 2023
K220870BioFire Global Fever Panel, BIOFIRE SHIELD Control Kit for the BioFire Global Fever PanelOctober 20, 2022
K221460BioFire COVID-19 Test 2July 25, 2022
K211079BioFire COVID-19 Test 2November 1, 2021
DEN200043FilmArray Global Fever PanelNovember 20, 2020
K202382FilmArray Global Fever Panel External Control KitNovember 20, 2020
K170883FilmArray NGDS Warrior PanelJune 22, 2017
DEN160048FilmArray NGDS Warrior PanelFebruary 14, 2017